Barclays lowered the firm’s price target on Sapiens (SPNS) to $30 from $38 and keeps an Underweight rating on the shares. The company’s lower than expected revenue and outlook were attributed to delays in software-as-a-service deal closings, among other things, the analyst tells investors in a research note. The firm reduced estimates post the print.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPNS: